Work

Clinical outcomes after first-line EGFR inhibitor treatment for patients with NSCLC, EGFR mutation, and poor performance status.

Year: 2013

Type: article

Study design: Observational Study

Source: PubMed

Authors: Yusuke Okuma, Yukio Hosomi, Makoto Nagamata, Yuko Yamada, Kuniko Sekihara, Kan Kato, Tsunekazu Hishima, Tatsuru Okamura

Institutions: Tokyo Metropolitan Komagome Hospital, National Cancer Center Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2249538727

FWCI: 0.713

Cites:

Cited by: 13

Related to: 10